West Pharmaceutical Services, Inc. Stock
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 248.95 USD | +7.48% |
|
+7.71% | -9.52% |
| 02-05 | West Pharmaceutical Services, Inc. - Special Call | |
| 02-03 | Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $320 From $390 | MT |
| Capitalization | 17.91B 15.16B 13.9B 13.16B 24.44B 1,623B 25.55B 161B 63.93B 781B 67.17B 65.79B 2,812B | P/E ratio 2025 * |
36.2x | P/E ratio 2026 * | 32.1x |
|---|---|---|---|---|---|
| Enterprise value | 17.43B 14.76B 13.53B 12.81B 23.79B 1,579B 24.87B 157B 62.22B 760B 65.38B 64.03B 2,737B | EV / Sales 2025 * |
5.69x | EV / Sales 2026 * | 5.28x |
| Free-Float |
95.72% | Yield 2025 * |
0.33% | Yield 2026 * | 0.35% |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | +7.48% | ||
| 1 week | +7.71% | ||
| Current month | +7.71% | ||
| 1 month | -11.35% | ||
| 3 months | -9.58% | ||
| 6 months | +4.92% | ||
| Current year | -9.52% |
| 1 week | 228 |  | 249.64 |
| 1 month | 223.83 | | 283.44 |
| Current year | 223.83 | | 291.38 |
| 1 year | 187.43 | | 325.2 |
| 3 years | 187.43 | | 415.73 |
| 5 years | 187.43 | | 475.35 |
| 10 years | 53.88 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 56 | 24/04/2015 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 04/08/2025 |
Quintin Lai
IRC | Investor Relations Contact | 59 | 11/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Hofmann
BRD | Director/Board Member | 74 | 16/10/2007 |
Mark Buthman
BRD | Director/Board Member | 65 | 01/02/2011 |
Douglas Michels
BRD | Director/Board Member | 69 | 07/03/2011 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -1.34% | 1.02% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +7.48% | +7.71% | -24.67% | -7.17% | 17.91B | |
| +1.60% | +1.40% | -13.56% | +0.07% | 193B | |
| -0.05% | -0.06% | +13.30% | +20.72% | 132B | |
| +2.01% | +0.01% | +45.96% | +132.54% | 69.89B | |
| +1.70% | +3.21% | -7.57% | -16.05% | 59.84B | |
| -1.84% | +2.22% | +36.21% | +85.77% | 56.95B | |
| +2.38% | +7.01% | - | - | 39.36B | |
| +0.11% | -4.20% | -20.78% | -34.44% | 27.29B | |
| +3.42% | -3.98% | +11.85% | +17.48% | 24.75B | |
| -1.93% | -5.52% | -16.56% | -49.60% | 20.45B | |
| Average | +1.49% | -0.32% | +2.69% | +16.59% | 64.11B | |
| Weighted average by Cap. | +1.12% | +0.71% | +4.83% | +23.74% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.06B 2.59B 2.38B 2.25B 4.18B 278B 4.37B 27.63B 10.94B 134B 11.49B 11.26B 481B | 3.25B 2.75B 2.52B 2.39B 4.44B 295B 4.64B 29.33B 11.61B 142B 12.2B 11.95B 511B |
| Net income | 498M 421M 386M 366M 679M 45.11B 710M 4.49B 1.78B 21.71B 1.87B 1.83B 78.17B | 562M 476M 436M 413M 767M 50.94B 802M 5.07B 2.01B 24.52B 2.11B 2.07B 88.28B |
| Net Debt | -477M -404M -370M -350M -651M -43.21B -680M -4.3B -1.7B -20.8B -1.79B -1.75B -74.88B | -719M -608M -558M -528M -980M -65.1B -1.03B -6.48B -2.56B -31.34B -2.69B -2.64B -113B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/02/26 | 248.95 $ | +7.48% | 1,481,074 |
| 05/02/26 | 231.62 $ | -2.29% | 1,154,365 |
| 04/02/26 | 237.05 $ | +2.64% | 1,690,392 |
| 03/02/26 | 230.95 $ | -2.76% | 944,365 |
| 02/02/26 | 237.50 $ | +2.76% | 1,203,482 |
Delayed Quote Nyse, February 07, 2026 at 12:00 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition